Home/Stocks/WGS

WGS

USD

GeneDx Holdings Corp. Class A Common Stock

$139.485+4.575 (3.391%)

Real-time Price

Healthcare

Diagnostics & Research

United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics

Company Fundamentals

Trading Stats

Market Metrics

Open

$134.910

High

$141.750

Low

$134.000

Volume

0.68M

Company Fundamentals

Market Cap

4.0B

Industry

Diagnostics & Research

Country

United States

Trading Stats

Avg Volume

0.58M

Exchange

NMS

Currency

USD

52-Week Range

Low $55.17Current $139.485High $146

Related News

Nov 4, 2025 · 04:05 PM

Analyst Upgrades

Wells Fargo Maintains Equal-Weight on GeneDx Holdings, Raises Price Target to $140

Wells Fargo analyst Brandon Couillard maintains GeneDx Holdings with a Equal-Weight and raises the price target from $95 to $140.

Oct 29, 2025 · 08:54 PM

Analyst Upgrades

Canaccord Genuity Maintains Buy on GeneDx Holdings, Raises Price Target to $160

Canaccord Genuity analyst Kyle Mikson maintains GeneDx Holdings with a Buy and raises the price target from $155 to $160.

Oct 29, 2025 · 12:43 PM

Analyst Upgrades

Guggenheim Maintains Buy on GeneDx Holdings, Raises Price Target to $170

Guggenheim analyst Subbu Nambi maintains GeneDx Holdings with a Buy and raises the price target from $115 to $170.

Oct 29, 2025 · 09:47 AM

Analyst Upgrades

BTIG Maintains Buy on GeneDx Holdings, Raises Price Target to $165

BTIG analyst Mark Massaro maintains GeneDx Holdings with a Buy and raises the price target from $140 to $165.

Oct 28, 2025 · 10:30 AM

BusinessWire

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

Reported third quarter 2025 revenues of $116.7 million with 65% year-over-year growth in exome and genome test revenue Accelerated exome and genome volume growth to 33% year-over-year Expanded adjusted gross

PR Newswire

Oct 27, 2025 · 12:00 PM

GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims

Schubert Jonckheer & Kolbe LLP reminds GeneDx Holdings Corp. (NASDAQ: WGS) investors that the firm is investigating potential legal claims relating...